• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00514200
Device Problem Migration (4003)
Patient Problem No Code Available (3191)
Event Date 11/16/2020
Event Type  Injury  
Manufacturer Narrative
(b)(6).(b)(4).The device has been received for analysis; however, the analysis has not yet been completed.Upon completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on november 16, 2020 that an ultraflex esophageal ng distal covered stent was implanted to treat a stenosis in the esophagus during a stent placement procedure performed on (b)(6) 2020.According to the complainant, the stent was deployed successfully.X-ray imaging was performed 24 hours post stent placement and it was confirmed that the stent was placed in the target location; however, on (b)(6) 2020, imaging was performed and it was noted that the stent had migrated almost into the patient's stomach.Reportedly, the stent was removed and the procedure was completed with another ultraflex esophageal stent.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2020 that an ultraflex esophageal ng distal covered stent was implanted to treat a stenosis in the esophagus during a stent placement procedure performed on (b)(6) 2020.According to the complainant, the stent was deployed successfully.X-ray imaging was performed 24 hours post stent placement and it was confirmed that the stent was placed in the target location; however, on (b)(6) 2020, imaging was performed and it was noted that the stent had migrated almost into the patient's stomach.Reportedly, the stent was removed and the procedure was completed with another ultraflex esophageal stent.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Block e1: initial reporter's facility name: (b)(6).Block h6: patient code 3191 is being used to capture the secondary procedure performed to remove the migrated stent.Device problem code 4003 captures the reportable event of stent migration.Block h10: an ultraflex esophageal covered stent was received for analysis; the delivery system was not returned.Visual inspection was performed and the loops of the stent were found bent.No other issues were noted to the stent.The reported event of stent migration was not confirmed as it is impossible to replicate the failure reported occurred during the procedure on the laboratory during analysis of the device.It is most likely that the factors encountered during the procedure, the patient's anatomy, and the technique used by the user during the stent placement could have caused the migration into the patient's stomach.Additionally, the stent loops were bent; however, there is insufficient information about what could be the cause for this failure.Stent migration is noted within the ifu as a known potential adverse event related to the use of the device.Therefore, a review and analysis of all available information indicated the most probable cause is known inherent risk of device.A review of the manufacturing documentation for this device revealed that no anomalies or deviations related to the event occurred during manufacturing.A labeling review was performed, and from the information available, this device was used per the instructions for use (ifu)/ product label.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key10967510
MDR Text Key220200381
Report Number3005099803-2020-05905
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729121190
UDI-Public08714729121190
Combination Product (y/n)N
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 01/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/10/2021
Device Model NumberM00514200
Device Catalogue Number1420
Device Lot Number0024745046
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/03/2020
Initial Date Manufacturer Received 11/16/2020
Initial Date FDA Received12/08/2020
Supplement Dates Manufacturer Received12/15/2020
Supplement Dates FDA Received01/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient Weight74
-
-